PMS49 Cost-Effectiveness Analysis of Etanercept and Infliximab in the Treatment of Rheumatoid Arthritis (RA) in Spain
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1404
https://www.valueinhealthjournal.com/article/S1098-3015(12)03117-8/fulltext
Title :
PMS49 Cost-Effectiveness Analysis of Etanercept and Infliximab in the Treatment of Rheumatoid Arthritis (RA) in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03117-8&doi=10.1016/j.jval.2012.08.1404
First page :
A448
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
902